Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Cancers|February 22, 2018
Recommendations and Choices for BRCA Mutation Carriers at Risk for Ovarian Cancer: A Complicated DecisionKelsey E Lewis, Karen H Lu, Amber M Klimczak, et al.International Urogynecology Journal|September 25, 2023
Patient experiences following prolapse surgery implementing a same-day discharge model: a prospective studyEmily R Aldrich, Kelsey E Lewis, Marlana M Mcdowell, et al.International Journal of Women'S Health|April 22, 2024
Same-Day Discharge is Safe, Feasible Following Vaginal Hysterectomy with Apical SuspensionMarlana M Ray, Jennifer Yeung, Jonathan Hoehn, et al.Urogynecology (Philadelphia, Pa.)|May 18, 2026
Quality Improvement Analysis of Operative Regimen on Urinary Tract InfectionsMildrede N Bonglack, Meredith H Carrel-Lammert, Jonathan M Hoehn, et al.The American Surgeon|June 3, 2015
Operative failure rate and documentation of family history in young patients undergoing focused parathyroidectomy for primary hyperparathyroidismElsa T Stephen, Amy R Quillo, Kelsey E Lewis, et al.Journal of Assisted Reproduction and Genetics|March 7, 2018
Embryonal mitochondrial DNA: relationship to embryo quality and transfer outcomesAmber M Klimczak, Lucia E Pacheco, Kelsey E Lewis, et al.Urogynecology (Philadelphia, Pa.)|April 8, 2025
A Randomized Controlled Trial for Dual-Agent Local Analgesic in Sling SurgeryMildrede N Bonglack, Marlana M Ray, Meredith H Carrel-Lammert, et al.Cancers|February 9, 2021
Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. <i>Cancers</i> 2020, <i>12</i>, 2436Wen Hu, Li Zhang, Sammy Ferri-Borgogno, et al.Cancers|September 2, 2020
Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant PhenotypeWen Hu, Li Zhang, Sammy Ferri-Borgogno, et al.Pageof 1